SEC Form 4 · Rule 10b5-1 trading plans
X4 Pharmaceuticals, Inc (XFOR)
- 5Trades filed under a plan
- 1Plan adoption dates stated
- 0Quarterly results prints on file
- 0Trades in the days before a print
In the 2025 filing year, X4 Pharmaceuticals, Inc filed 5 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 5 reporting owners, covering 5 transactions filed under those plans and 214,287 shares. None carries the SEC's own AFF10B5ONE adoption flag; each of the 5 names a plan in a footnote. No results print is on file in this window, so no interval is measured.
Trades filed under a plan in X4 Pharmaceuticals, Inc 5
- Arbet-Engels Christophe — 2025-01-24 · S · 11,624 shares
- Baldry Mark — 2025-01-24 · S · 29,159 shares
- DiBiase Mary — 2025-01-24 · S · 22,258 shares
- Mostafa Adam S. — 2025-01-24 · S · 74,773 shares
- Ragan Paula — 2025-01-24 · S · 76,473 shares
Plan adoption dates stated in X4 Pharmaceuticals, Inc 1
- 2024-06-28 — stated in 5 filings
Quarterly results prints on file in X4 Pharmaceuticals, Inc 0
Trades in the days before a print in X4 Pharmaceuticals, Inc 0
Interval to the next reported results date
For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.
- 0Within 5 days of a print
- 0Within 10 days of a print
- —Shortest interval, in days
- 5Trades with no later print on file
Adoption dates, as the filings state them
- 2024-06-28 stated in 5 filings
As the filings state it: “10b5-1 trading plan adopted by the Reporting Person on June 28, 2024”
Order the document
Every company with plan records →
Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.